Abstract: A display device includes a display panel, an input sensor operating in an input sensing mode or a proximity sensing mode, a sensor controller driving the input sensor in the input sensing mode or the proximity sensing mode, and a main controller controlling driving of the sensor controller. The input sensor includes a sensing area and a non-sensing area. The sensing area is divided into a proximity sensing area and a plurality of reference areas in the proximity sensing mode. The main controller generates a noise control signal based on a plurality of reference sensing signals sensed in the reference areas, and determines whether an object is in proximity based on the noise control signal and a proximity sensing signal sensed in the proximity sensing area.

Abstract: A method of driving an input sensor to detect a proximity of a user includes driving the input sensor in a direct sensing mode, the input sensor including first sensing electrodes and second sensing electrodes insulated from the first sensing electrodes, and upon determining the user is engaged in a call, driving the input sensor in in a first proximity sensing mode by applying a driving signal to each of the first sensing electrodes. when the user has not performed the direct touch, and driving the input sensor in a second proximity sensing mode by applying no driving signal to a first subset of the first sensing electrodes and applying the driving signal to a second other subset of the first sensing electrodes, when the user has performed the direct touch.

Abstract: The present invention pertains to the use of the protein phenylalanine ammonia-lyase, as well as the biologically-active derivatives of the said protein for preventing or treating diseases associated with a phenylalanine imbalance in a human or animal body. More particularly, the present invention relates to the therapeutic use of the above-cited molecules for preventing or treating a phenylalanine imbalance in vivo. This invention also deals with therapeutic compositions comprising a pharmaceutically active amount of the above-described therapeutic molecules as well as with therapeutic methods using the said therapeutic compositions. Finally, the present invention relates to processes for selecting more therapeutically-effective variants of said protein as well as to the selected variants themselves.

Abstract: The present invention pertains to the use of the protein phenylalanine ammonia-lyase, as well as the biologically-active derivatives of the said protein for preventing or treating diseases associated with a phenylalanine imbalance in a human or animal body. More particularly, the present invention relates to the therapeutic use of the above-cited molecules for preventing or treating a phenylalanine imbalance in vivo. This invention also deals with therapeutic compositions comprising a pharmaceutically active amount of the above-described therapeutic molecules as well as with therapeutic methods using the said therapeutic compositions. Finally, the present invention relates to processes for selecting more therapeutically-effective variants of said protein as well as to the selected variants themselves.